EYPT Q1 2019 Earnings — EyePoint Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena

EYPTEyePoint Pharmaceuticals, Inc.

$1B

Q1 2019 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$2M+116.8% YoY

Gross Profit

$2M83.6% margin

Operating Income

-$15M-728.2% margin

Net Income

-$19M-956.2% margin

EPS (Diluted)

$-2.02

QoQ Revenue Growth

-17.6%

Cash Flow

Operating Cash Flow

-$13M

Free Cash Flow

-$14M

Stock-Based Comp.

$1M

Balance Sheet

Total Assets

$82M

Total Liabilities

$62M

Stockholders' Equity

$20M

Cash & Equivalents

$43M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$2M	$928,000	+116.8%
Gross Profit	$2M	-$2M	+170.2%
Operating Income	-$15M	-$5M	-213.2%
Net Income	-$19M	-$7M	-175.7%

Revenue Segments

Product

$543,000100%